Vanguard Group »

Bridgebio Pharma shares owned by Vanguard Group

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $356M 14M 25.33
2024-03-31 $409M 13M 30.92
2023-12-31 $517M 13M 40.37
2023-09-30 $297M 11M 26.37
2023-06-30 $201M 12M 17.20
2023-03-31 $200M 12M 16.58
2022-12-31 $81M 11M 7.62
2022-06-30 $90M 9.9M 9.08
2022-03-31 $96M 9.4M 10.15
2021-09-30 $442M 9.4M 46.87
2021-06-30 $691M 11M 60.96
2021-03-31 $575M 9.3M 61.60
2020-12-31 $458M 6.4M 71.11
2020-09-30 $236M 6.3M 37.52
2020-06-30 $189M 5.8M 32.61
2020-03-31 $69M 2.4M 29.00
2019-12-31 $75M 2.1M 35.05
2019-09-30 $34M 1.6M 21.48